Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Etoricoxib

An anti-inflammatory of the coxib family, a selective COX-2 inhibitor: patented in 1996 and approved in 2002, it is used for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It blocks COX-2, the enzyme that fuels inflammation, about 106 times more than COX-1, its 'sister' enzyme that protects the stomach lining.

EtoricoxibGo to the active ingredient →
EtoricoxibActive ingredientEtoricoxibCat. No. P-E140-001CAS 202409-33-4
Etoricoxib-d3Isotopically labelledEtoricoxib-d3Cat. No. P-E140-004CAS 850896-71-8
Etoricoxib-D4Isotopically labelledEtoricoxib-D4Cat. No. P-E140-005CAS 1131345-14-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.